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Introduction

Discussion

Conclusion

Cryptococcus Neoformans is a pathogenic yeast that is acquired
from the environment via inhalation. However, pulmonary
infection is uncommon. Cryptococcosis usually manifests as a CNS
or disseminated infection especially in immunocompromised
patients. Infection of the pleural space with C. Neoformans is quite
uncommon [1].

Cryptococcal pleural effusions are often reactive and sterile that
may resolve spontaneously or respond to surgical drainage well [2].
The immune status is the most important determinant of the
subsequent course of the infection by C. Neoformans [3]. Most
cases of cryptococcal empyemic pleural effusions were limited to
severe immunosuppressed patients [4]. The factors that determine
whether an exposed person develops symptomatic infection
include the inoculum of fungi and/or virulence factors of the
infecting strain. Unlike bacterial empyema, there is no consensus
on how to define fungal empyema or specific recommendations
for treatment including indications for drainage via chest tube.
Common symptoms include cough, sputum production,
hemoptysis, dyspnea, chest pain, fever, malaise, night sweats and
weight loss [5].

This patient is an example of a changing spectrum of
cryptococcal pleural disease that is conventionally believed to be
confined to immunocompromised patients. A serum cryptococcal
antigen was diagnostic in our case and should be included in the
diagnostic evaluation of unexplained pleural empyema/effusion
in an immunocompetent patient. Aggressive surgical
debridement and concurrent antifungal chemotherapy predict a
successful clinical outcome.

Case Presentation
A 66 year old man with past medical history of diabetes was
admitted because of right sided pleuritic chest pain. Patient was
afebrile and hemodynamically stable. Patient had decreased air
entry on auscultation of the right lung. Imaging showed loculated
right sided pleural effusion (Figure 1). Pleural fluid culture grew
Streptococcus Intermedius. A chest tube was placed. He then
underwent thoracotomy and decortication of the right pleura. As
well, patient received a complete course of appropriate
antimicrobials (i.e., ceftriaxone and metronidazole and then,
clindamycin after discharge). The pleural peel fungal culture grew
Cryptococcus Neoformans one month later.
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The patient was thus seen at the Infectious Diseases clinic. He was
still complaining of ongoing fatigue and right sided pleuritic chest
pain, but he denied fevers, chills, night sweats, cough, dyspnea,
headaches, stiff neck, nausea, vomiting and photophobia. Serum
cryptococcal antigen was positive at 1:80, so he was started on
oral fluconazole for 4 months along with serial cryptococcal
antigen assays during the treatment course.
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Figure 1: Right sided loculated pleural effusion

